Operating Income for Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's current operating income (TTM) is $116.97M USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$116.97M
YoY change
-50.5%
5Y CAGR
-8.3%
Peak year (2023)
$298.94M
Cumulative operating income
$3.80B
Operating Income history chart for Bio-Techne (TECH) from 1989 to 2025
Operating Income history table for Bio-Techne (TECH) from 1989 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $102.25M | -50.5% | ||
| 2024 | $206.69M | -30.9% | ||
| 2023 | $298.94M | +0.8% | ||
| 2022 | $296.59M | +25.0% | ||
| 2021 | $237.30M | +50.7% | ||
| 2020 | $157.42M | +25.4% | ||
| 2019 | $125.58M | -7.8% | ||
| 2018 | $136.18M | +11.8% | ||
| 2017 | $121.78M | -19.1% | ||
| 2016 | $150.59M | +2.4% | ||
| 2015 | $147.02M | -8.0% | ||
| 2014 | $159.75M | +0.8% | ||
| 2013 | $158.47M | -4.7% | ||
| 2012 | $166.21M | +1.9% | ||
| 2011 | $163.06M | +4.3% | ||
| 2010 | $156.33M | +3.7% | ||
| 2009 | $150.78M | +4.5% | ||
| 2008 | $144.29M | +16.2% | ||
| 2007 | $124.15M | +14.4% | ||
| 2006 | $108.50M | +11.0% | ||
| 2005 | $97.76M | +18.8% | ||
| 2004 | $82.27M | +21.5% | ||
| 2003 | $67.72M | +28.2% | ||
| 2002 | $52.82M | +15.3% | ||
| 2001 | $45.81M | +16.4% | ||
| 2000 | $39.34M | +56.8% | ||
| 1999 | $25.10M | +18.4% | ||
| 1998 | $21.20M | +38.6% | ||
| 1997 | $15.30M | +25.4% | ||
| 1996 | $12.20M | +29.8% | ||
| 1995 | $9.40M | +23.7% | ||
| 1994 | $7.60M | +10.1% | ||
| 1993 | $6.90M | +68.3% | ||
| 1992 | $4.10M | +86.4% | ||
| 1991 | $2.20M | +46.7% | ||
| 1990 | $1.50M | +150.0% | ||
| 1989 | $600,000 | — |
Operating Income values are taken from Bio-Techne's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Bio-Techne (TECH) most recent annual operating income stands at $102.25M (2025) – plunged 50.5% year-over-year.
Across 2020–2025 (5 years), Bio-Techne operating income produced a CAGR of -8.3% – with a net decline across the window.
Bio-Techne operating income peaked at $298.94M in 2023; the latest annual figure is $102.25M in 2025 (65.8% below peak).
Across the available history, operating income reached its high of $298.94M in 2023 and its low of $600,000 in 1989.
Within Healthcare, Bio-Techne (TECH) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
Bio-Techne Operating Income by Year
Bio-Techne Operating Income 2025: $102.25M
Bio-Techne operating income in 2025 was $102.25M, plunged 50.5% below 2024.
Bio-Techne Operating Income 2024: $206.69M
Bio-Techne operating income in 2024 was $206.69M, plunged 30.9% below 2023.
Bio-Techne Operating Income 2023: $298.94M
Bio-Techne operating income in 2023 was $298.94M, edged up 0.8% from 2022. This figure represents the highest annual value in the available history.
Bio-Techne Operating Income 2022: $296.59M
Bio-Techne operating income in 2022 was $296.59M, grew 25.0% from 2021.
Bio-Techne Operating Income 2021: $237.30M
Bio-Techne operating income in 2021 was $237.30M.
See more financial history for Bio-Techne (TECH).
Sector peers — Operating Income
Companies in the same sector as Bio-Techne, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Bio-Techne's operating income?
- Latest reported operating income for Bio-Techne (TECH) is $116.97M (period ending December 31, 2025).
How has Bio-Techne operating income changed year-over-year?
- Bio-Techne (TECH) operating income changed -50.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne operating income?
- Bio-Techne (TECH) operating income compound annual growth rate is -8.3% over the most recent 5 years available.
When did Bio-Techne operating income hit its highest annual value?
- Bio-Techne operating income reached its highest annual value of $298.94M in 2023.
What was Bio-Techne operating income in 2024?
- Bio-Techne (TECH) operating income in 2024 was $206.69M.
What was Bio-Techne operating income in 2025?
- Bio-Techne (TECH) operating income in 2025 was $102.25M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.